Key Takeaways Recursion uses its AI platform, RecursionOS, to simulate drug interactions and speed up discovery. Partnerships with Bayer and Roche validate RXRX's model and provide recurring tech-licensing revenues. RXRX faces growing competition from TechBio peers like RLAY and SDGR with similarly advanced platforms.Recursion Pharmaceuticals (RXRX) is redefining the traditional model of drug discovery by harnessing the power of artificial intelligence (AI) through its proprietary RecursionOS platform, de ...

SandRidge Energy Inc. (SD) has received an upgrade to "Neutral," reflecting a more constructive albeit cautious view of the company’s prospects. This recalibrated stance is grounded in three pillars — strengthening natural gas pricing, maintaining a resilient balance sheet and projecting meaningful production upside for the second half of 2025.Though headwinds such as volatile oil prices and capital allocation sensitivity remain, SandRidge Energy’s fundamentals suggest a stable outlook that merits the revis ...

Key Takeaways NVDA leads major chip peers in YTD gains and hovers near a fresh 52-week high. Data Center revenues hit $39.1B in Q1 FY26, fueled by strong AI chip demand and new GPU platforms. Despite China's export curbs, NVDA expects Q2 revenues of $45B, a 50% increase from the prior year.NVIDIA Corporation (NVDA) stands as a titan in the semiconductor industry, powered by its strong presence in the artificial intelligence (AI) chip space and solid financial health. The stock closed at $153.30 on July 1, ...

All amounts expressed in US dollars KINSHASA, Democratic Republic of Congo, July 02, 2025 (GLOBE NEWSWIRE) -- Barrick Mining Corporation (NYSE:B)(TSX:ABX) – Drilling results from the ARK-KCD corridor continue to strengthen confidence in its scale and continuity, demonstrating the potential to host significant additional orebodies and further extend the life of mine at Kibali, Africa’s biggest and greenest gold mine. Speaking at a media briefing in Kinshasa today, Barrick president and chief executive Mark B ...

Marijuana Stock Recovery Ahead? What 2025 Trends Signal a Bullish Outlook for Cannabis InvestorsEven with a current downturn in marijuana stock performance, the long-term outlook for cannabis investing remains promising. For financial investors with a patient, strategic mindset, the sector’s current pullback may offer one of the most tempting buying opportunities in years. Market sentiment has been dulled by halting federal reform and overhyped early growth expectations. Along with underlying industry funda ...

I’m passionate about finance and investing, focusing on business analysis, fundamental analysis, valuation, and long-term growth, especially in sectors like AI, fintech, finance and tech. I study finance and economy and have hands-on experience in equity research, financial modeling, and creating investment content. I actively analyze publicly traded companies with a focus on business models, earnings performance, and competitive positioning. I also run a finance-focused YouTube channel called “The Market M ...

About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...

Key Takeaways LULU's Q1 revenues rose 22% in China and 17% in Rest of World, reinforcing full-year global growth targets. Comparable sales in the Americas fell 1%, as U.S. traffic softened despite premium activewear share gains. Product launches like Align No Line and Daydrift may help offset domestic caution in the back half.lululemon athletica inc.’s (LULU) international business remains a key growth driver, with first-quarter fiscal 2025 revenues in the China Mainland growing 22% and Rest of World risi ...

Moretus Research delivers state-of-the-art, buy-side quality equity research for serious investors seeking clarity, conviction, and alpha. Focused on U.S. public markets, Moretus applies a structured, repeatable framework to identify companies with durable business models, mispriced cash flow potential, and intelligent capital allocation. Built on institutional standards, Moretus Research combines rigorous fundamental analysis with a high-signal, judgment-driven process—eschewing noise, narrative, and overl ...

Group 1 - The announcement indicates that no stabilisation was carried out for the securities offered by PAPREC HOLDING, as per the Market Abuse Regulation [2] - The securities issued by PAPREC HOLDING include an aggregate nominal amount of EUR 550 million with a 4.125% interest rate due on 15 July 2030 and EUR 300 million with a 4.5% interest rate due on 15 July 2032 [3] - The offer price for the securities is set at 100/100, indicating a par value offering [3] Group 2 - The stabilisation managers for the securities are BNP Paribas, CACIB, Natixis, and SG [4] - The announcement clarifies that the securities are not being offered for sale in the United States and have not been registered under the United States Securities Act of 1933 [5][7] - There will not be a public offer of the securities in the United States, emphasizing the restricted nature of the offering [6][7]